Vivesto
0.08 SEK
-0.98 %
Less than 1K followers
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vivesto
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -10.0 | 1.2 | -27.4 | -7.8 | -8.9 | -7.1 | -8.7 | -32.6 |
| EBIT | -10.8 | -11.0 | -42.0 | -8.6 | -9.7 | -7.1 | -8.9 | -34.4 |
| EBIT-% | ||||||||
| Profit before taxes | -10.3 | -10.7 | -39.8 | -8.3 | -9.5 | -7.2 | -9.1 | -34.1 |
| Net income | -10.3 | -10.7 | -39.8 | -8.3 | -9.5 | -7.2 | -9.1 | -34.1 |